Variant report
Variant | nsv897625 |
---|---|
Chromosome Location | chr11:62839667-62881839 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:62848664..62851040-chr11:62854770..62857085,2 | MCF-7 | breast: | |
2 | chr11:62851942..62854202-chr11:62871987..62874309,2 | K562 | blood: | |
3 | chr11:62851942..62854202-chr11:62871987..62874309,2 | K562 | blood: | |
4 | chr11:62848664..62851040-chr11:62854770..62857085,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs544004260 | chr11:62848010-62848011 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs114753444 | chr11:62848021-62848022 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs532922948 | chr11:62848033-62848034 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs546571739 | chr11:62848034-62848035 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs559921438 | chr11:62848039-62848040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs35839122 | chr11:62848053-62848054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs529317001 | chr11:62848069-62848070 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs116618100 | chr11:62848070-62848071 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs549662424 | chr11:62848087-62848088 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs569575412 | chr11:62848116-62848117 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs538402032 | chr11:62848135-62848136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs34936614 | chr11:62848165-62848166 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs551728297 | chr11:62848181-62848182 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs111597569 | chr11:62848184-62848185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs148836630 | chr11:62848186-62848187 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs188222815 | chr11:62848189-62848190 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs565967566 | chr11:62848216-62848217 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs536270930 | chr11:62848254-62848255 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs555194054 | chr11:62848315-62848316 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs575182847 | chr11:62848318-62848319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs369807279 | chr11:62848342-62848343 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs531515623 | chr11:62848366-62848367 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs10897341 | chr11:62848367-62848368 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs577645435 | chr11:62848381-62848382 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs376649497 | chr11:62848413-62848414 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs11231340 | chr11:62848445-62848446 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs11231341 | chr11:62848487-62848488 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs75726395 | chr11:62848517-62848518 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs370756811 | chr11:62848518-62848519 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs373626890 | chr11:62848534-62848535 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs11231342 | chr11:62848568-62848569 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs142507239 | chr11:62848585-62848586 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs571785330 | chr11:62848589-62848590 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs537781152 | chr11:62854861-62854862 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs117311387 | chr11:62854917-62854918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs374039638 | chr11:62854925-62854926 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs186137346 | chr11:62854936-62854937 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs557195624 | chr11:62854990-62854991 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs140977572 | chr11:62855023-62855024 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs547374736 | chr11:62855025-62855026 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs7927104 | chr11:62855031-62855032 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
42 | rs536266635 | chr11:62855066-62855067 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs548957476 | chr11:62855105-62855106 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs11231347 | chr11:62855111-62855112 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs537634051 | chr11:62855209-62855210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs375519686 | chr11:62855219-62855220 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs557977371 | chr11:62855224-62855225 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs150211619 | chr11:62855225-62855226 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs138727273 | chr11:62855284-62855285 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs533909364 | chr11:62855374-62855375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Autism | 22495311 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Glioblastoma multiforme | 21138945 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Breast cancer | 21364760 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Pituitary adenoma | 18645599 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Prostate cancer | 18632612 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Smith-Lemli-Opitz syndrome | 21572526 | CNVD |
Multiple myeloma | 16461302 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Chordoma | 21602918 | CNVD |
Melanoma | 18172304 | CNVD |
Chordoma | 18071362 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
ovarian endometriomas | 16273235 | CNVD |
Breast cancer | 21785460 | CNVD |
Breast cancer | 20409316 | CNVD |
Spinal muscular atrophy | 17160897 | CNVD |
Retinitis pigmentosa | 17160897 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:62848000-62848600 | Enhancers | HepG2 | liver |
2 | chr11:62854800-62855400 | Enhancers | HUES6 Cell Line | embryonic stem cell |
3 | chr11:62855000-62855400 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
4 | chr11:62863400-62864200 | Enhancers | Gastric | stomach |
5 | chr11:62863600-62864000 | Enhancers | Fetal Intestine Large | intestine |
6 | chr11:62873800-62874000 | ZNF genes & repeats | ES-I3 Cell Line | embryonic stem cell |